224 related articles for article (PubMed ID: 19048115)
21. Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs).
Upadhyaya M; Kluwe L; Spurlock G; Monem B; Majounie E; Mantripragada K; Ruggieri M; Chuzhanova N; Evans DG; Ferner R; Thomas N; Guha A; Mautner V
Hum Mutat; 2008 Jan; 29(1):74-82. PubMed ID: 17960768
[TBL] [Abstract][Full Text] [Related]
22. Absolute quantification of somatic DNA alterations in human cancer.
Carter SL; Cibulskis K; Helman E; McKenna A; Shen H; Zack T; Laird PW; Onofrio RC; Winckler W; Weir BA; Beroukhim R; Pellman D; Levine DA; Lander ES; Meyerson M; Getz G
Nat Biotechnol; 2012 May; 30(5):413-21. PubMed ID: 22544022
[TBL] [Abstract][Full Text] [Related]
23. Germline and Somatic
Wang X; Kallionpää RA; Gonzales PR; Chitale DA; Tousignant RN; Crowley JP; Chen Z; Yoder SJ; Blakeley JO; Acosta MT; Korf BR; Messiaen LM; Tainsky MA
Cancer Prev Res (Phila); 2018 Oct; 11(10):655-664. PubMed ID: 30104415
[No Abstract] [Full Text] [Related]
24. TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer.
Chien J; Sicotte H; Fan JB; Humphray S; Cunningham JM; Kalli KR; Oberg AL; Hart SN; Li Y; Davila JI; Baheti S; Wang C; Dietmann S; Atkinson EJ; Asmann YW; Bell DA; Ota T; Tarabishy Y; Kuang R; Bibikova M; Cheetham RK; Grocock RJ; Swisher EM; Peden J; Bentley D; Kocher JP; Kaufmann SH; Hartmann LC; Shridhar V; Goode EL
Nucleic Acids Res; 2015 Aug; 43(14):6945-58. PubMed ID: 25916844
[TBL] [Abstract][Full Text] [Related]
25. Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.
Singer G; Stöhr R; Cope L; Dehari R; Hartmann A; Cao DF; Wang TL; Kurman RJ; Shih IeM
Am J Surg Pathol; 2005 Feb; 29(2):218-24. PubMed ID: 15644779
[TBL] [Abstract][Full Text] [Related]
26. Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients.
Wimmer K; Yao S; Claes K; Kehrer-Sawatzki H; Tinschert S; De Raedt T; Legius E; Callens T; Beiglböck H; Maertens O; Messiaen L
Genes Chromosomes Cancer; 2006 Mar; 45(3):265-76. PubMed ID: 16283621
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic implications of NF1 gene alterations in diffuse gliomas.
Vizcaíno MA; Shah S; Eberhart CG; Rodriguez FJ
Hum Pathol; 2015 Sep; 46(9):1323-30. PubMed ID: 26190195
[TBL] [Abstract][Full Text] [Related]
28. Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations.
Pros E; Fernández-Rodríguez J; Canet B; Benito L; Sánchez A; Benavides A; Ramos FJ; López-Ariztegui MA; Capellá G; Blanco I; Serra E; Lázaro C
Hum Mutat; 2009 Mar; 30(3):454-62. PubMed ID: 19241459
[TBL] [Abstract][Full Text] [Related]
29. Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors.
Tworek H; Peng R; Fetzer S; Werness BA; Piver MS; Allen HJ; DiCioccio RA
Cancer Genet Cytogenet; 1999 Jul; 112(2):105-18. PubMed ID: 10686936
[TBL] [Abstract][Full Text] [Related]
30. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
Havrilesky LJ; Alvarez AA; Whitaker RS; Marks JR; Berchuck A
Gynecol Oncol; 2001 Dec; 83(3):491-500. PubMed ID: 11733961
[TBL] [Abstract][Full Text] [Related]
31. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.
Messiaen LM; Callens T; Mortier G; Beysen D; Vandenbroucke I; Van Roy N; Speleman F; Paepe AD
Hum Mutat; 2000; 15(6):541-55. PubMed ID: 10862084
[TBL] [Abstract][Full Text] [Related]
32. Intraindividual genomic heterogeneity of high-grade serous carcinoma of the ovary and clinical utility of ascitic cancer cells for mutation profiling.
Choi YJ; Rhee JK; Hur SY; Kim MS; Lee SH; Chung YJ; Kim TM; Lee SH
J Pathol; 2017 Jan; 241(1):57-66. PubMed ID: 27741368
[TBL] [Abstract][Full Text] [Related]
33. Homozygous deletion of MKK4 in ovarian serous carcinoma.
Nakayama K; Nakayama N; Davidson B; Katabuchi H; Kurman RJ; Velculescu VE; Shih IeM; Wang TL
Cancer Biol Ther; 2006 Jun; 5(6):630-4. PubMed ID: 16627982
[TBL] [Abstract][Full Text] [Related]
34. Clonal lineage of high grade serous ovarian cancer in a patient with neurofibromatosis type 1.
Norris EJ; Jones WD; Surleac MD; Petrescu AJ; Destephanis D; Zhang Q; Hamadeh I; Kneisl JS; Livasy CA; Ganapathi RN; Tait DL; Ganapathi MK
Gynecol Oncol Rep; 2018 Feb; 23():41-44. PubMed ID: 29892687
[TBL] [Abstract][Full Text] [Related]
35. Somatic alterations of the NF1 gene in an NF1 individual with multiple benign tumours (internal and external) and malignant tumour types.
Spurlock G; Griffiths S; Uff J; Upadhyaya M
Fam Cancer; 2007; 6(4):463-71. PubMed ID: 17551851
[TBL] [Abstract][Full Text] [Related]
36. Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras.
Yunoue S; Tokuo H; Fukunaga K; Feng L; Ozawa T; Nishi T; Kikuchi A; Hattori S; Kuratsu J; Saya H; Araki N
J Biol Chem; 2003 Jul; 278(29):26958-69. PubMed ID: 12730209
[TBL] [Abstract][Full Text] [Related]
37. Neurofibromatosis type 1 (NF1): a protein truncation assay yielding identification of mutations in 73% of patients.
Park VM; Pivnick EK
J Med Genet; 1998 Oct; 35(10):813-20. PubMed ID: 9783703
[TBL] [Abstract][Full Text] [Related]
38. Germline and somatic NF1 gene mutations in plexiform neurofibromas.
Upadhyaya M; Spurlock G; Monem B; Thomas N; Friedrich RE; Kluwe L; Mautner V
Hum Mutat; 2008 Aug; 29(8):E103-11. PubMed ID: 18484666
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of 7 new established cell lines from high grade serous ovarian cancer.
Kreuzinger C; Gamperl M; Wolf A; Heinze G; Geroldinger A; Lambrechts D; Boeckx B; Smeets D; Horvat R; Aust S; Hamilton G; Zeillinger R; Cacsire Castillo-Tong D
Cancer Lett; 2015 Jul; 362(2):218-28. PubMed ID: 25862976
[TBL] [Abstract][Full Text] [Related]
40. Fifty-four novel mutations in the NF1 gene and integrated analyses of the mutations that modulate splicing.
Xu W; Yang X; Hu X; Li S
Int J Mol Med; 2014 Jul; 34(1):53-60. PubMed ID: 24789688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
